FDA label 9a2ac669-27ef-4908-84ee-c5ed10fa22c9

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

SPL set ID
5673820a-b926-4478-9aae-3999bbd861a7
SPL ID
9a2ac669-27ef-4908-84ee-c5ed10fa22c9
Version
1
Effective date
2009-11-14
Source export date
2026-09-28
Source partition
9
Source file
https://download.open.fda.gov/drug/label/drug-label-0009-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-09-28/6784607726c827491ceaeab30d843632e0660ee8008c535197be5ed9e1e52201/drug-label-0009-of-0014.json.zip
Source manifest SHA-256
cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run
20260929T050834Z
Imported at
2026-09-29 06:00:21

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

W ARNING ! EXTREMELY COLD OXYDIZING LIQUID AND GAS UNDER PRESSURE. VIGOROUSLY ACCELERATES COMBUSTION. CAN CAUSE SEVERE FROSTBITE. COMBUSTABLES IN CONTACT WITH LIQUID OXYGEN MAY EXPLODE ON IGNITION OR IMPACT. Do not drop. Use hand truck for container movement. Keep oil, grease and combustibles away. Keep away from heat, sparks, and flame. Use with equipment cleaned for oxygen service. Do not get liquid in eyes, on skin or on clothing. For liquid withdrawal wear face shield or goggles, and gloves. Avoid spills. Don not walk on or roll equipment over spills. Store and use with adequate ventilation to prevent oxygen accumulation. Close valve when not in use and when empty. Container discharge must be warmed to room temperature before breathing. Always secure container so it cannot be knocked over. Use per Praxair MSDS P-4637 and safe practices information P-3499 (obtain from your supplier) and manufactures operating instructions for this container. FIRST AID: IN CASE OF FROSTBITE, obtain medical treatment immediately. WARNING! For emergency use only when administered by properly trained personnel for Oxygen deficiency and resuscitation. For all other medical applications, RX only. Uninterrupted use of high concentrations of oxygen over a long duration, without monitoring its effect on oxygen content of arterial blood, may be harmful. Use only with pressure reducing equipment and apparatus designed for oxygen. Do not attempt to use on patients who have stopped breathing unless used in conjunction with resuscitative equipment. Container temperature should not exceed 125 degrees Fahrenheit. IN CASE OF EMERGENCY: CALL 800-424-9300 ORSINI HEALTHCARE MADE IN USA DO NOT REMOVE THIS LABEL Elk Grove Village, IL

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.